Jennifer Tsoi

Amgen (United States)

Papers

1

Total Citations

11

H-Index

1

About

Jennifer Tsoi’s research centers on the development and application of advanced bioanalytical platforms, particularly electrochemiluminescence (ECL) technologies for macromolecular analysis. Her most-cited work, “Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range” (2009), critically evaluates the practical utility of planar ECL systems in regulated environments, highlighting both their strengths—such as enhanced sensitivity and throughput—and their constraints, including dynamic range challenges. This contribution has been foundational for researchers navigating the trade-offs between assay performance and regulatory compliance in biotherapeutic development. With 11 citations, the paper reflects her ability to bridge fundamental analytical chemistry with real-world biopharmaceutical needs. Tsoi’s work is notable for its pragmatic focus on translating laboratory innovations into robust, regulatory-acceptable methods, making her a key voice in the evolution of bioanalytical strategies. Her insights continue to inform best practices for macromolecule characterization, benefiting both academic labs and industrial quality control settings.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range
11 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago